Episode 108
Sandra Fryhofer, MD, discusses new J&J vaccine recommendations
AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.
December 21, 202116m 36s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.
Topics
mrnaboostersvaccinationcoronavirusvaccines for kidscovid-19